Skip to main content

Table 2 Self-reported abstinence at each visit

From: Effectiveness of a pharmacist-delivered smoking cessation program in the State of Qatar: a randomized controlled trial

  Responders ITT
Variable Intervention Control p-value Intervention Control p-value
Outcome measure at 3 months
 7 days abstinence 31/101 (30.7%) 26/98 (26.5%) 0.516 31/167 (18.6%) 26/147 (17.7%) 0.841
 30 days abstinence 27/101 (26.7%) 22/98 (22.4%) 0.483 27/167 (16.2%) 22/147 (15.0%) 0.770
 Continuous abstinence 25/101 (24.8%) 21/98 (21.4%) 0.578 25/167 (15.0%) 21/147 (14.3%) 0.864
Outcome measure at 6 months
 7 days abstinence 28/100 (28.0%) 21/99 (21.2%) 0.324 28/167 (16.8%) 21/147 (14.3%) 0.546
 30 days abstinence 27/100 (27.0%) 20/99 (20.2%) 0.259 27/167 (16.2%) 20/147 (13.6%) 0.525
 Continuous abstinence 23/100 (23.0%) 20/99 (20.2%) 0.632 23/167 (13.8%) 20/147 (13.6%) 0.966
Outcome measure at 12 months
 7 days abstinence 21/88 (23.9%) 14/83 (16.9%) 0.257 21/167 (12.6%) 14/147 (9.5%) 0.391
 30 days abstinence 21/88 (23.9%) 14/83 (16.9%) 0.257 21/167 (12.6%) 14/147 (9.5%) 0.391
 Continuous abstinence 21/88 (23.9%) 14/83 (16.9%) 0.257 21/167 (12.6%) 14/147 (9.5%) 0.391
Continuous abstinence at 12 months incorporating data from visits 3 and 6 and 12‡ 9/68 (13.2%) 6/68 (8.8%) 0.412 9/167 (5.4%) 6/147 (4.1%) 0.588
  1. ‡this includes only participants who completed assessment of all outcome measures up to the time indicated